Tenon Medical, Inc. (TNON)
NASDAQ: TNON · IEX Real-Time Price · USD
0.651
-0.016 (-2.40%)
At close: Jul 19, 2024, 4:00 PM
0.670
+0.019 (2.92%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Company Description
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico.
The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Tenon Medical, Inc.
| Country | United States |
| Founded | 2012 |
| IPO Date | Apr 27, 2022 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 21 |
| CEO | Steven M. Foster |
Contact Details
Address: 104 Cooper Ct. Los Gatos, California 95032 United States | |
| Phone | (408) 649-5760 |
| Website | tenonmed.com |
Stock Details
| Ticker Symbol | TNON |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001560293 |
| CUSIP Number | 88066N105 |
| ISIN Number | US88066N2045 |
| Employer ID | 45-5574718 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Foster | Chief Executive Officer, President and Director |
| Richard M. Ferrari | Founder and Executive Chairman |
| Richard Ginn | Founder, Chief Technology Officer and Director |
| Steven M. Van Dick | Executive Vice President of Finance and Administration and Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 15, 2024 | DEFR14A | Filing |
| Jul 15, 2024 | DEFR14A | Filing |
| Jul 10, 2024 | 424B3 | Prospectus |
| Jul 5, 2024 | 424B3 | Prospectus |
| Jul 3, 2024 | EFFECT | Notice of Effectiveness |
| Jul 3, 2024 | 424B3 | Prospectus |
| Jul 2, 2024 | 424B3 | Prospectus |
| Jul 1, 2024 | EFFECT | Notice of Effectiveness |
| Jun 25, 2024 | EFFECT | Notice of Effectiveness |
| Jun 21, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |